| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |